Detalles de la búsqueda
1.
Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.
BMC Cancer
; 23(1): 1078, 2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940878
2.
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.
BMC Cancer
; 22(1): 310, 2022 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321690
3.
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
Oncologist
; 26(6): e1066-e1072, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811782
4.
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials.
BMC Cancer
; 21(1): 832, 2021 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281514
5.
Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.
Oncologist
; 25(3): e469-e476, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162797
6.
Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
Support Care Cancer
; 28(12): 5943-5952, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32281034
7.
Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.
Biomed Chromatogr
; 30(7): 1150-1154, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26525154
8.
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial.
Lung Cancer
; 192: 107801, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678830
9.
Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer.
Anticancer Res
; 43(2): 725-732, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36697059
10.
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
Anticancer Res
; 43(3): 1301-1307, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854494
11.
Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy.
Anticancer Res
; 43(5): 2351-2357, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097664
12.
Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.
J Cancer
; 14(5): 676-688, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37056385
13.
Efficacy of cisplatin plus vinorelbine adjuvant chemotherapy with split-dose administration of cisplatin after complete resection of stage II-IIIA non-small cell lung cancer.
Mol Clin Oncol
; 16(4): 76, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251627
14.
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.
J Pharm Health Care Sci
; 8(1): 8, 2022 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236407
15.
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.
Mol Clin Oncol
; 16(4): 91, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251642
16.
Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy.
Mol Clin Oncol
; 14(6): 116, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903822
17.
Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy.
Anticancer Res
; 41(3): 1615-1620, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788757
18.
Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer.
Lung Cancer
; 134: 1-6, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319966
19.
Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial.
BMJ Open
; 9(7): e028056, 2019 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278102
20.
Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
Anticancer Res
; 38(11): 6367-6373, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396959